Publication | Open Access

Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial

Radiation MedicineOncologyRadiation TherapyThyroid DiseaseNrg/rtog 0912Cancer TreatmentPhase 2MedicineRadiation OncologyAnaplastic Thyroid Cancer